MX9400174A - Sesquiterpenos, procedimiento para su preparacion, cepa fungal que los produce y composiciones farmaceuticas o veterinarias que los incluyen. - Google Patents

Sesquiterpenos, procedimiento para su preparacion, cepa fungal que los produce y composiciones farmaceuticas o veterinarias que los incluyen.

Info

Publication number
MX9400174A
MX9400174A MX9400174A MX9400174A MX9400174A MX 9400174 A MX9400174 A MX 9400174A MX 9400174 A MX9400174 A MX 9400174A MX 9400174 A MX9400174 A MX 9400174A MX 9400174 A MX9400174 A MX 9400174A
Authority
MX
Mexico
Prior art keywords
fungal strain
produces
squiterpenes
pharmaceutical
procedure
Prior art date
Application number
MX9400174A
Other languages
English (en)
Inventor
Didier Vincent Renno
Gerard Bernard O'beirne
Brent Raymond Copp
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of MX9400174A publication Critical patent/MX9400174A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se describen sesquiterpenos, que se pueden obtener de la cepa fungal Acremonium strictum X06/15/458, y sales farmacéutica y veterinariamente aceptables de los mismos, que son inhibidores del enlace de la benzodiazepina al complejo receptor de ionóforo GABA-benzo-diazepina-C1-. Estos compuestos se preparan al (i) fermentar, en una fuente de carbono, nitrógeno y sales inorgánicas, la cepa fungal XO6/15/458 (IMI 354451) o un mutante de la misma, que produce los sesquiterpenos, (ii) aislar los sesquiterpenos del medio de fermentación; y (iii) si se desea, convertir el sesquiterpeno en una sal farmacéutica o veterinariamente aceptable del mismo.
MX9400174A 1992-12-22 1994-01-03 Sesquiterpenos, procedimiento para su preparacion, cepa fungal que los produce y composiciones farmaceuticas o veterinarias que los incluyen. MX9400174A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226724A GB9226724D0 (en) 1992-12-22 1992-12-22 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
MX9400174A true MX9400174A (es) 1994-07-29

Family

ID=10727034

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9400174A MX9400174A (es) 1992-12-22 1994-01-03 Sesquiterpenos, procedimiento para su preparacion, cepa fungal que los produce y composiciones farmaceuticas o veterinarias que los incluyen.

Country Status (23)

Country Link
US (1) US5565486A (es)
EP (1) EP0675888A1 (es)
JP (1) JPH08504804A (es)
KR (1) KR950704324A (es)
AU (1) AU677272B2 (es)
BG (1) BG99736A (es)
BR (1) BR9307712A (es)
CA (1) CA2151251A1 (es)
CZ (1) CZ284121B6 (es)
FI (1) FI953081A0 (es)
GB (2) GB9226724D0 (es)
HU (1) HUT71859A (es)
IL (1) IL108140A (es)
MX (1) MX9400174A (es)
NO (1) NO952483L (es)
NZ (1) NZ258986A (es)
PL (1) PL309628A1 (es)
RU (1) RU95113350A (es)
SG (1) SG67345A1 (es)
SK (1) SK77595A3 (es)
TW (1) TW242141B (es)
WO (1) WO1994014814A1 (es)
ZA (1) ZA939626B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070161095A1 (en) * 2005-01-18 2007-07-12 Gurin Michael H Biomass Fuel Synthesis Methods for Increased Energy Efficiency
CA2797033C (en) 2010-04-22 2021-10-19 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
US9789164B2 (en) 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348284A (ja) * 1986-08-18 1988-02-29 Yamanouchi Pharmaceut Co Ltd 新抗生物質yp−02908l−aおよびその製造法
EP0301102B1 (en) * 1987-02-06 1991-11-06 Snow Brand Milk Products Co., Ltd. NOVEL 7$g(b)-HYDROXY-4-PREGNENE-3,20-DIONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
JP2842613B2 (ja) * 1989-04-28 1999-01-06 塩野義製薬株式会社 フォスフォリパーゼa▲下2▼阻害物質
JPH03108490A (ja) * 1989-06-30 1991-05-08 Shionogi & Co Ltd フォスフォリパーゼa↓2阻害物質
US5130430A (en) * 1990-10-31 1992-07-14 Neurogen Corporation 2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
US5189050A (en) * 1991-06-03 1993-02-23 Merck & Co., Inc. Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder

Also Published As

Publication number Publication date
GB9503413D0 (en) 1995-04-12
CZ164695A3 (en) 1995-11-15
IL108140A (en) 1997-06-10
NZ258986A (en) 1996-11-26
GB2284603B (en) 1996-03-27
AU5709694A (en) 1994-07-19
HUT71859A (en) 1996-02-28
TW242141B (es) 1995-03-01
IL108140A0 (en) 1994-04-12
CZ284121B6 (cs) 1998-08-12
BR9307712A (pt) 1999-08-31
EP0675888A1 (en) 1995-10-11
BG99736A (bg) 1996-04-30
CA2151251A1 (en) 1994-07-07
HU9501840D0 (en) 1995-08-28
NO952483D0 (no) 1995-06-21
JPH08504804A (ja) 1996-05-28
KR950704324A (ko) 1995-11-17
FI953081A (fi) 1995-06-21
US5565486A (en) 1996-10-15
PL309628A1 (en) 1995-10-30
FI953081A0 (fi) 1995-06-21
GB2284603A (en) 1995-06-14
WO1994014814A1 (en) 1994-07-07
NO952483L (no) 1995-08-15
SG67345A1 (en) 1999-09-21
RU95113350A (ru) 1997-06-10
AU677272B2 (en) 1997-04-17
SK77595A3 (en) 1995-12-06
GB9226724D0 (en) 1993-02-17
ZA939626B (en) 1994-08-18

Similar Documents

Publication Publication Date Title
NZ333385A (en) Solid oral dosage forms containing 35% of valsartan
CA2176713A1 (en) Amphiphilic Imidazolinium Derivatives
FI962487A (fi) Rapamysiinijohdannaisia
DE69327100D1 (de) Gemisch mit hohem gehalt an cis beta-carotin
NO951613L (no) Ikke-peptidyl tachykinin reseptorantagonister
SE9303627D0 (sv) Method and means for prevention of cataract
DE69328776D1 (de) Rekonstruiertes knorpelgewebe
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
GEP20002330B (en) Tricyclic Pyrimidin Derivatives Capable of Inhibiting Tyrozine Kinases Epidermic Growth Factor Receptor, Pharmaceutical Composition Containing Them and Methods for Treatment
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
ES2145254T3 (es) Formulaciones de aerosoles que contienen flunisolida.
WO1996011949A3 (en) Analogs of keratinocyte growth factor
IL127542A0 (en) Administration regimen of H+ K+ -ATPase inhibitors
AU5846494A (en) Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
NO995928L (no) Alfa-1-antitrypsin-preparater samt fremgangsmåte ved fremstilling derav
AU7335696A (en) Water-soluble vitamin composition that provides excellent tablets and process for producing the same
ES2174054T3 (es) Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico.
DK0482183T3 (da) Histamin-H3-receptoragonistforbindelser til terapeutisk anvendelse, farmaceutiske sammensætninger virkende som agonister for nævnte receptor og fremstillingsmetode
MX9400174A (es) Sesquiterpenos, procedimiento para su preparacion, cepa fungal que los produce y composiciones farmaceuticas o veterinarias que los incluyen.
HU9500559D0 (en) New mercapto-acetamide tricyclic derivatives as enkephalinase-inhibitors
ES2194933T3 (es) Inhibidores de la agregacion plaquetaria.
NO985679D0 (no) Dihydrobenzopyran og beslektede forbindelser nyttige som anti-inflammasjonsmidler
TW231970B (es)
PL331942A1 (en) Method of biologically transforming colchicinoid compounds into their correcponding 3-glycoside derivatives
BG99313A (en) 117-alkylketonesteroids as 5- -reductase inhibitors